At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Fluoxetinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Childhood Depression: Remission and Relapse
University of Texas Southwestern Medical Center·interventional·Posted Jun 2, 2006·Updated Jan 8, 2014
In Brief
A clinical study evaluating Fluoxetine for Depression. Completed, across 1 site.
Detailed Summary
This study will determine the optimal length of continuation treatment with fluoxetine for children and adolescents with major depressive disorder, as well as the factors that may contribute to positive response during acute and continuation treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2000
Study CompletionOct 2005
First PostedJun 2006
TodayJul 2026
First PostedJun 2, 2006
Enrollment StartJun 1, 2000
Study CompletionOct 1, 2005
TodayJul 2, 2026
Posted 20.1 years ago
Interventions
Fluoxetinedrug